His interests and expertise include MR spectroscopy, brain tumors, and positron emission tomography (PET). Dr. Wilson's primary research is in the development of new molecular imaging biomarkers for cancer detection and characterization, employing hyperpolarized 13C MR spectroscopy and PET, for improved evaluation of tumors and other disorders with underlying metabolic abnormalities. In particular, he has been developing techniques for in vivo characterization of redox potential and applying them to intracranial tumors, neurodegenerative diseases, and drug treatment models.